Background and objective: Systemic inflammation is a well-known risk factor for diseases such as atherosclerosis and is augmented by the presence of obesity. In addition, it has been shown that inflammation may be negatively influenced by certain macronutrients, specifically the omega-3 and omega-6 fatty acids. The primary aim of this study is to determine whether obesity modifies the association between plasma phospholipid polyunsaturated fatty acids (PUFAs) and markers of inflammation and endothelial activation in Multi-Ethnic Study of Atherosclerosis (MESA) participants. Subjects: A sample of 2848 adults (25% African American, Chinese, Hispanic, and White) randomly selected from the MESA cohort. Measurements: Relative plasma PUFA concentrations were determined using gas chromatography-flame ionization detection. Levels of three inflammatory markers (high-sensitivity C-reactive protein, interleukin (IL)-6 and tumor necrosis factor-receptor 1) and two endothelial activation markers (soluble intercellular adhesion molecule-1 (sICAM-1) and E-selectin) were determined with enzyme immunoassays. Linear regression analysis was used to evaluate the relationship between these markers and plasma PUFAs. Results: Obesity modified the associations of linoleic acid (P int ¼ 0.01), dihomo-g-linolenic (P int ¼ 0.07) and eicosapentaenoic acid (EPA) (P int ¼ 0.04) with sICAM-1 concentrations; in addition, obesity modified the association of IL-6 with dihomo-glinolenic (P int ¼ 0.01). In obese individuals, sICAM-1 was inversely related to EPA levels (P ¼ 0.02), but directly related to linoleic acid levels (Po0.001). Conversely, sICAM-1 was inversely related to linoleic acid levels in normal weight individuals (P ¼ 0.04). IL-6 concentrations were significantly and directly related to dihomo-g-linolenic acid (DGLA) in normal weight (P ¼ 0.01) and obese participants (Po0.001), but the scale of increase across tertiles was greater in obese adults. Main effects of fatty acid and inflammatory marker associations are also reported. Conclusion: The modifying effect of obesity on the association of plasma PUFAs with IL-6 and sICAM-1 suggests differences in fatty acid metabolism and may also have implications in dietary fatty acid intake for obese individuals, particularly for linoleic and EPAs. Further study is warranted to confirm and explain the strong associations of DGLA with inflammatory and endothelial activation markers.
Introduction
Inflammation and endothelial activation are associated with the development of chronic diseases including coronary heart disease and atherosclerosis. 1, 2 Indeed, inflammation within the endothelial wall is now considered a key component of atherosclerosis progression. 2 A number of environmental factors such as smoking 3 and obesity 4, 5 have long been recognized as promoters of inflammation and disease development; however, it has only recently gained acceptance that long chain polyunsaturated fatty acids (PUFAs) have the potential to reduce inflammation 6 as well as the risk of atherosclerosis 7 and cardiovascular disease events. [8] [9] [10] Most commonly associated with fish oil, omega-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been well studied since their association with lower rates of thrombosis and heart disease. 11 Plasma levels of these omega-3 PUFAs have since been inversely associated with circulating pro-inflammatory cytokines such as C-reactive protein, interleukin-6 (IL-6) and tumor necrosis factor a (TNF-a), as well as endothelial activation markers. [12] [13] [14] Further experiments using cell culture models have revealed a number of anti-inflammatory signaling pathways induced by EPA, DHA and their downstream metabolites. 15, 16 Though less wellstudied, the omega-3 PUFAs alpha-linolenic acid (ALA) and docosapentaenoic acid may show similar associations and anti-inflammatory characteristics.
Apart from the omega-3s, the omega-6 fatty acids found in nuts and oils rich in linoleic acid, for example safflower and corn oils, have garnered recent attention for their potential cardiovascular benefits, as well. [17] [18] [19] [20] Past investigators have largely focused on the relationship between inflammation and plasma omega-6 PUFAs linoleic acid (LA) and arachidonic acid (AA), [12] [13] [14] but to our knowledge, no studies have examined the relationship of inflammation/endothelial activation with plasma g-linolenic acid (GLA) or dihomo-glinolenic acid (DGLA). Overall, it remains unclear whether certain plasma omega-3 or omega-6 PUFA concentrations predict an inflammatory phenotype while others predict an anti-inflammatory phenotype. 21 In addition to the potential influence of specific omega-3 or omega-6 PUFAs on inflammation and endothelial activation, obesity is already a well-known promoter of both phenomena. 4, 5 Although previous studies have adjusted for body mass index (BMI) in statistical models, [12] [13] [14] no study has determined whether obesity influences the relationship between plasma PUFAs and markers of inflammation and endothelial activation. The purpose of this study is to determine the extent to which obesity and weight status modify the relationship between plasma phospholipid PUFAs and systemic inflammatory and endothelial activation markers in a large adult population.
Materials and methods

Population
The primary aim of Multi-Ethnic Study of Atherosclerosis (MESA) is to investigate the development and progression of subclinical cardiovascular disease. The study design has been described elsewhere, 22 The current analyses consist of a sample of 2848 randomly selected adults from the MESA cohort who gave informed consent (MESA Genetics Candidate Gene Evaluation Cohort). The study population was represented equally by each of the following races/ethnicities: African American (n ¼ 703), Asian (of Chinese descent n ¼ 712), Hispanic (n ¼ 709) and White (n ¼ 722) participants.
Measurements
Questionnaire information was obtained regarding age, sex, race/ethnicity, education, and lifestyle factors including smoking status, alcohol consumption and physical activity. Height (m) and weight (kg) were measured according to standard procedures. 22 Fasting blood was drawn and serum and EDTA-anticoagulant tubes were collected and processed using a standardized protocol. 22 The serum and plasma samples were aliquoted and stored at À70 1C until time of use.
Plasma fatty acid profile
Phospholipid fatty acids were extracted from EDTA plasma (n ¼ 2848) using the method previously described by Cao et al. 23 . In brief, lipids were extracted from the plasma using a chloroform/methanol extraction method and the cholesteryl esters, triglyceride, phospholipids and free fatty acids were separated by thin layer chromatography. Fatty acids from the phospholipids were derivatized to methyl esters and detected by gas chromatography flame ionization detection. The fatty acids detected were expressed as a percent of total fatty acids. ). Baseline characteristics are presented as means (s.d.) for continuous variables and frequencies (%) for categorical variables and stratified by weight status. Levels of biomarkers with skewed distributions were log transformed prior to analysis and results were back transformed and presented as geometric means. Generalized linear regression analysis evaluated levels of biomarkers across tertiles of plasma phospholipid PUFAs, adjusting for age, gender, race/ethnicity, field center, education, smoking, physical activity, energy intake, HDL, LDL, triglycerides and diagnosed diabetes. Interaction terms were included in the models to determine whether weight status modified the relations between plasma phospholipid PUFAs and biomarkers. Multiple comparisons were evaluated in linear regression analysis using Tukey's test. Tests for interaction were considered significant at Pp0.10.
Results
Baseline characteristics are shown in Table 1 . Average age was 62.1±10.2 years, over 50% were female, and the majority of adults had greater than a high school education. The subcohort is composed of B25% of each race/ethnicity in the MESA study, including African Americans, Chinese, Hispanics and Whites. Only 13.7% were smokers; however, 67% of adults were current drinkers. Among this sample, 32.3% were of normal weight, 38.7% overweight and 29% were obese.
All markers of inflammation and endothelial activation were higher with greater adiposity levels, shown in Figures 1a and b , (all trends, Po0.001).
As shown in Table 2 , weight status modified the relations between plasma fatty acids and IL-6 and ICAM-1. For the omega-6 PUFAs, sICAM-1 levels were greater across tertiles of LA in obese adults, but the opposite trend was observed in normal weight adults (P interaction ¼ 0.01). Although levels of sICAM-1 were greater across tertiles of DGLA in all weight classes, the scale of increase across tertiles was greater in obese adults compared with normal or overweight adults (P interaction ¼ 0.07). For omega-3 PUFAs, sICAM-1 decreased across tertiles of EPA and (EPA þ DHA) among obese adults, whereas no relation was observed in those who were normal weight or overweight (P interaction ¼ 0.04 for EPA;
Finally, weight status modified the relation between DGLA and IL-6 (P interaction ¼ 0.01). Similar to sICAM-1, the levels of IL-6 were significantly greater across tertiles of DGLA in normal weight and obese participants, but again the scale of increase across tertiles was greater in obese adults. Although it did not reach significance, IL-6 levels were highest in individuals in the highest tertile of DGLA compared with tertiles 1 and 2 among overweight participants (P ¼ 0. 17) .
No other modifying effect of adiposity reached significance, and main effects data for plasma phospholipid PUFAs relative to markers of inflammation are shown in Tables 3  and 4 . Generally, several of the markers of inflammation or Table 1 Unadjusted baseline characteristics of a selected sample of participants enrolled in the multi-ethnic study of atherosclerosis, n ¼ 2846 Plasma fatty acids, inflammation and obesity BT Steffen et al endothelial activation were lower in the highest tertiles of omega-6 PUFAs LA and AA and the omega-3 fatty acids ALA, EPA, docosapentaenoic acid, DHA and (EPA þ DHA). In contrast, inflammatory markers were higher in the highest tertiles of omega-6 PUFAs GLA and DGLA.
Discussion
In the present cross-sectional study, obesity was found to modify the associations of several PUFAs (LA, DGLA, EPA and EPA þ DHA) with sICAM-1 or IL-6. More significant associations were generally observed between PUFAs and concentrations of inflammatory markers in obese compared with normal weight or overweight adults. Additionally, we confirm previous findings that (1) obese individuals have elevated markers of inflammation and endothelial activation 24, 25 and (2) modest but significant differences in PUFA composition were evident among weight classes.
26,27
Obesity, plasma phospholipid composition, and markers of inflammation and endothelial activation Obese individuals had significantly lower levels of omega-3 PUFAs (ALA, docosapentaenoic acid and DHA) and the omega-6 PUFA, LAFbut the presence of obesity resulted in significantly higher levels of omega-6 PUFAs GLA, DGLA and AA compared with normal or overweight adults (data not shown). Though variations in diet and fatty acid absorption may contribute to the above observations, differences in the activities of fatty acid metabolic enzymes have been reported in an animal model of obesity 28 as well as in obese human subjects 29 and may account for such variations in plasma PUFA composition. Overall, the origin(s) of altered PUFA Models were adjusted for age, gender, race/ethnicity, center, education, smoking, physical activity and energy intake. **Significantly different among all groups. P for trends o0.001. (b) Levels of endothelial markers across weight categories. Models were adjusted for age, gender, race/ethnicity, center, education, smoking, physical activity and energy intake. **Significantly different among all groups. *Significantly different between normal weight and obsese, and between overweight and obsese; P for trends o0.001. Plasma fatty acids, inflammation and obesity BT Steffen et al composition in obese adults is unclear, but may be the product of diet, metabolism and/or absorption differences. In addition to modifying PUFA composition, the presence of obesity altered the relations of fatty acids with sICAM-1 and IL-6. Although normal weight individuals with relatively high plasma LA levels showed significantly lower levels of sICAM-1, the reverse was found in obese individuals. In addition, high plasma levels of EPA and (EPA þ DHA) were associated with lower levels of sICAM-1 among obese participants, yet no association was observed in non-obese individuals. As sICAM-1 is both a marker of endothelial activation and a predictor of future cardiovascular disease events, 30 these findings may have implications for PUFA intake in obese versus non-obese individuals, if confirmed.
PUFAs and markers of inflammation and endothelial activation Omega-6 PUFAs. Expectedly, omega-6 fatty acids were found to be differentially associated with markers of inflammation and endothelial activation; however, the pattern of these associations was not expected. Indeed, GLA and DGLA have been documented for their conversion into the series-1 prostanoids 31 and suppression of inflammatory leukotriene (LT) formation, 32 yet they were positively associated with inflammatory and endothelial activation markers with a more significant association found in obese adults. Converse to GLA and DGLA, plasma LA and AA were found to be inversely associated with inflammatory markers. Given that AA has been characterized for inducing inflammation through its metabolism into inflammatory LTs, an inverse association with IL-6 was not expected. However, the formation of pro-inflammatory LTs from AA is a tightly regulated process, 33 thus moderate elevations in AA levels may have little to no net effect on LT production and resulting inflammation. Alternatively, the metabolism of AA into the anti-inflammatory lipoxin A 4 34 and the reported suppressive effect of AA on the transcription factor nuclear Abbreviations: AA, arachidonic acid; DGLA, dihomo-g-linolenic acid; FA, fatty acid; GLA, g-linolenic acid; hsCRP, high-sensitivity C-reactive protein; IL, interleukin; LA, linoleic acid; sICAM-1, soluble intercellular adhesion molecule-1; TNF, tumor necrosis factor receptor. NA: not applicable as joint effects were reported in Table 2. a Adjusted for age, gender, race/ethnicity, field center, education, smoking, physical activity and energy intake.
b Adjusted further for body mass index, high-density lipoprotein, low-density lipoprotein, triglycerides and diagnosed diabetes. Finally, LA has previously been recognized for its benefits in reducing both total and LDL cholesterol, 38 ,39 yet its inconsistent associations with inflammatory markers [12] [13] [14] make it unclear whether relatively higher plasma levels in the present study population are beneficial in the context of inflammation. Similar to Kalogeropoulos et al., 14 our findings provide evidence for a potential benefit as individuals in the highest tertile of plasma LA had the lowest levels of highsensitivity C-reactive protein and E-selectin. Overall, further research of omega-6 fatty acids and their metabolism is warranted to more fully explain their putative roles in inflammation and endothelial activation.
Omega-3 PUFAs. As expected, plasma EPA and (EPA þ DHA) were found to be inversely associated with inflammation and endothelial activation markers, and previous studies have outlined a host of mechanisms by which EPA may influence inflammatory pathways. 40 Apart from these well-reviewed mechanisms, EPA also generates non-classical eicosanoids Famong them, the powerful anti-inflammatory E-series resolvins. 41 . The resolvins were recently discovered and subsequently shown to reduce leukocytes-endothelial interaction, 42 suppress production of inflammatory stimuli, 43 and promote the resolution of inflammation. 44 In addition, EPA may also directly downregulate inflammatory genes by suppressing nuclear factor-kB activity as shown in cell culture models, 45, 46 potentially through activation of PPARs. 47 Ultimately, it is likely that EPA influences inflammation and endothelial activation through some combination of the above factors. In agreement with a number of previous studies, 13, 14 we found that plasma levels of DHA were negatively associated with markers of inflammation, IL-6 and TNF-R1. Similar to EPA, DHA generates powerful anti-inflammatory non-classic eicosanoids, including the D-series resolvins, maresins and protectins, 48 which may account for the negative correlations observed here.
Strengths and limitations
This study is the largest to date that examines plasma PUFAs relative to selected biomarkers. Plasma PUFAs were measured to avoid the problems of dietary questionnaires, that is, inaccurate self-reporting and assumptions of uniform in vivo fatty acid metabolism. This analysis is limited by the crosssection study design, which eliminates the possibility of determining temporality of relationships. We also examined the effect modification of weight status as determined by BMIFfuture studies may benefit from measuring visceral fat, that is, central adiposity or percentage of body fat. Based on a previous report, 49 we did not include Black participants in sICAM-1 data analysis as a common single nucleotide polymorphism polymorphism in Blacks results in an underestimation of this analyte. Finally, we controlled for factors that may influence inflammation and endothelial activation, but the possibility of residual confounders cannot be excluded.
Conclusions
It has largely been accepted that higher levels of omega-3 PUFAs lead to reduced risk of cardiovascular disease, high plasma EPA and (EPA þ DHA) levels with concomitantly lower plasma LA levels appear especially important among obese individuals in reducing the likelihood of high levels of sICAM-1. The current cross-sectional study offers insight, but prospective studies are needed to determine whether higher plasma or cell membrane levels of omega-3 fatty acids and other PUFAs directly influence inflammation and subsequent risk for disease development, particularly in obese individuals. Finally, further study is also warranted to confirm and explain the strong associations of DGLA with inflammatory and endothelial activation markers.
